Published in Diabetes Care on January 01, 2013
Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med (2014) 6.51
Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care (2013) 4.85
Trends in prevalence and control of diabetes in the United States, 1988-1994 and 1999-2010. Ann Intern Med (2014) 4.00
Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med (2014) 3.38
National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations. JAMA Intern Med (2014) 3.00
Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study. Lancet Diabetes Endocrinol (2014) 2.34
Underuse of the health care system by persons with diabetes mellitus and diabetic macular edema in the United States. JAMA Ophthalmol (2014) 2.23
Adherence to therapies in patients with type 2 diabetes. Diabetes Ther (2013) 2.23
Comparison of HOMA-IR, HOMA-β% and disposition index between US white men and Japanese men in Japan: the ERA JUMP study. Diabetologia (2014) 2.21
Limited recovery of β-cell function after gastric bypass despite clinical diabetes remission. Diabetes (2013) 2.19
Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. Lancet Diabetes Endocrinol (2014) 2.19
Effect of patients' risks and preferences on health gains with plasma glucose level lowering in type 2 diabetes mellitus. JAMA Intern Med (2014) 2.17
Improving diabetes prevention with benefit based tailored treatment: risk based reanalysis of Diabetes Prevention Program. BMJ (2015) 2.10
Diagnosing gestational diabetes mellitus: rationed or rationally related to risk? Diabetes Care (2013) 2.04
Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone. Diabetes Obes Metab (2014) 1.99
Early childhood investments substantially boost adult health. Science (2014) 1.96
Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg (2013) 1.91
Guidelines abstracted from the American Geriatrics Society Guidelines for Improving the Care of Older Adults with Diabetes Mellitus: 2013 update. J Am Geriatr Soc (2013) 1.87
The effect of an EDTA-based chelation regimen on patients with diabetes mellitus and prior myocardial infarction in the Trial to Assess Chelation Therapy (TACT). Circ Cardiovasc Qual Outcomes (2013) 1.84
Rationale and design of the glycemia reduction approaches in diabetes: a comparative effectiveness study (GRADE). Diabetes Care (2013) 1.79
Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial. Lancet Diabetes Endocrinol (2016) 1.59
Consensus statement on management of dyslipidemia in Indian subjects. Indian Heart J (2014) 1.57
Use of HbA1c for diagnoses of diabetes and prediabetes: comparison with diagnoses based on fasting and 2-hr glucose values and effects of gender, race, and age. Metab Syndr Relat Disord (2014) 1.53
Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Diabetes Care (2014) 1.47
Clinical Decision Support Systems and Prevention: A Community Guide Cardiovascular Disease Systematic Review. Am J Prev Med (2015) 1.47
Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review. Diabetes Metab Syndr Obes (2013) 1.47
Tackling the growing diabetes burden in Sub-Saharan Africa: a framework for enhancing outcomes in stroke patients. J Neurol Sci (2014) 1.46
A real-world study of the effect of timing of insulin initiation on outcomes in older medicare beneficiaries with type 2 diabetes mellitus. J Am Geriatr Soc (2015) 1.45
Environmental chemicals and type 2 diabetes: an updated systematic review of the epidemiologic evidence. Curr Diab Rep (2013) 1.44
Associations of Low-Intensity Resistance Training with Body Composition and Lipid Profile in Obese Patients with Type 2 Diabetes. PLoS One (2015) 1.44
Relation between BMI and diabetes mellitus and its complications among US older adults. South Med J (2015) 1.44
Time Trends in Ischemic Stroke among Type 2 Diabetic and Non-Diabetic Patients: Analysis of the Spanish National Hospital Discharge Data (2003-2012). PLoS One (2015) 1.43
Glycemic control and diabetes management in hospitalized patients in Brazil. Diabetol Metab Syndr (2013) 1.43
Chaperonin-containing t-complex protein-1 subunit β as a possible biomarker for the phase of glomerular hyperfiltration of diabetic nephropathy. Dis Markers (2015) 1.41
Preadmission metformin use and mortality among intensive care patients with diabetes: a cohort study. Crit Care (2013) 1.40
Managing diabetes with nanomedicine: challenges and opportunities. Nat Rev Drug Discov (2014) 1.39
Type 2 Diabetes Risk Allele Loci in the Qatari Population. PLoS One (2016) 1.38
Closed-loop artificial pancreas systems: physiological input to enhance next-generation devices. Diabetes Care (2014) 1.37
Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus. PLoS One (2014) 1.37
Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes. J Clin Endocrinol Metab (2014) 1.29
Risk stratification by self-measured home blood pressure across categories of conventional blood pressure: a participant-level meta-analysis. PLoS Med (2014) 1.29
Diabetes and employment. Diabetes Care (2013) 1.28
Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction. J Am Coll Cardiol (2014) 1.27
Telemedicine application in the care of diabetes patients: systematic review and meta-analysis. PLoS One (2013) 1.27
Using appropriate body mass index cut points for overweight and obesity among Asian Americans. Prev Med (2014) 1.26
A Comparison of Health Plan- and Provider-Delivered Chronic Care Management Models on Patient Clinical Outcomes. J Gen Intern Med (2016) 1.22
Change in cardiovascular risk factors following early diagnosis of type 2 diabetes: a cohort analysis of a cluster-randomised trial. Br J Gen Pract (2014) 1.17
Glycemic control among patients in China with type 2 diabetes mellitus receiving oral drugs or injectables. BMC Public Health (2013) 1.16
Gestational diabetes mellitus in Africa: a systematic review. PLoS One (2014) 1.15
Kidney disease and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care (2014) 1.15
Early diabetic nephropathy: a complication of reduced insulin sensitivity in type 1 diabetes. Diabetes Care (2013) 1.14
Prevalence of prediabetes in England from 2003 to 2011: population-based, cross-sectional study. BMJ Open (2014) 1.13
Prevalence and Management of Dyslipidemia in Korea: Korea National Health and Nutrition Examination Survey during 1998 to 2010. Diabetes Metab J (2013) 1.12
Glycemic control in young children with diabetes: the role of parental health literacy. Patient Educ Couns (2013) 1.12
Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™). Cardiovasc Diabetol (2014) 1.12
Empirically establishing blood glucose targets to achieve HbA1c goals. Diabetes Care (2014) 1.11
Novel use and utility of integrated electronic health records to assess rates of prediabetes recognition and treatment: brief report from an integrated electronic health records pilot study. Diabetes Care (2013) 1.11
Tofogliflozin, a novel sodium-glucose co-transporter 2 inhibitor, improves renal and pancreatic function in db/db mice. Br J Pharmacol (2013) 1.10
The ARMS-D out performs the SDSCA, but both are reliable, valid, and predict glycemic control. Diabetes Res Clin Pract (2013) 1.10
Fecal microbiota imbalance in Mexican children with type 1 diabetes. Sci Rep (2014) 1.10
Antihypertensive medication initiation among young adults with regular primary care use. J Gen Intern Med (2014) 1.09
Health coaching by medical assistants to improve control of diabetes, hypertension, and hyperlipidemia in low-income patients: a randomized controlled trial. Ann Fam Med (2015) 1.09
Age at type 2 diabetes onset and glycaemic control: results from the National Health and Nutrition Examination Survey (NHANES) 2005-2010. Diabetologia (2013) 1.08
KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD. Am J Kidney Dis (2013) 1.08
2014 hypertension recommendations from the eighth joint national committee panel members raise concerns for elderly black and female populations. J Am Coll Cardiol (2014) 1.08
The independent contribution of diabetic foot ulcer on lower extremity amputation and mortality risk. J Diabetes Complications (2014) 1.08
Accuracy and robustness of dynamical tracking of average glycemia (A1c) to provide real-time estimation of hemoglobin A1c using routine self-monitored blood glucose data. Diabetes Technol Ther (2013) 1.08
A multicenter, prospective, randomized, double-blind study to evaluate the safety and efficacy of Saroglitazar 2 and 4 mg compared with placebo in type 2 diabetes mellitus patients having hypertriglyceridemia not controlled with atorvastatin therapy (PRESS VI). Diabetes Technol Ther (2013) 1.07
Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study. Diabetologia (2014) 1.06
Sex differences in diabetes and risk of incident coronary artery disease in healthy young and middle-aged adults. Diabetes Care (2013) 1.06
Tumor shrinkage with lanreotide Autogel 120 mg as primary therapy in acromegaly: results of a prospective multicenter clinical trial. J Clin Endocrinol Metab (2013) 1.06
Efficacy and safety of insulin degludec given as part of basal-bolus treatment with mealtime insulin aspart in type 1 diabetes: a 26-week randomized, open-label, treat-to-target non-inferiority trial. Diabetes Obes Metab (2014) 1.05
Lipid, blood pressure and kidney update 2013. Int Urol Nephrol (2014) 1.05
Diabetes mellitus, prediabetes, and incidence of subclinical myocardial damage. Circulation (2014) 1.05
Race/ethnic difference in diabetes and diabetic complications. Curr Diab Rep (2013) 1.05
Subclinical hypothyroidism is independently associated with microalbuminuria in a cohort of prediabetic egyptian adults. Diabetes Metab J (2013) 1.04
Factors associated with persistent poorly controlled diabetes mellitus: clues to improving management in patients with resistant poor control. Chronic Illn (2014) 1.03
The pharmacogenetics of type 2 diabetes: a systematic review. Diabetes Care (2014) 1.03
Effects of switching from insulin glargine or detemir to insulin degludec in patients with type 1 diabetes mellitus. Diabetes Ther (2013) 1.03
Health coaching and genomics-potential avenues to elicit behavior change in those at risk for chronic disease: protocol for personalized medicine effectiveness study in air force primary care. Glob Adv Health Med (2013) 1.03
Sex specific incidence rates of type 2 diabetes and its risk factors over 9 years of follow-up: Tehran Lipid and Glucose Study. PLoS One (2014) 1.02
Ethical complexities in standard of care randomized trials: A case study of morning versus nighttime dosing of blood pressure drugs. Clin Trials (2015) 1.02
Diabetes and beta cell function: from mechanisms to evaluation and clinical implications. Biochem Med (Zagreb) (2013) 1.01
Repurposing diabetes drugs for brain insulin resistance in Alzheimer disease. Diabetes (2014) 1.01
Severe Hypoglycemia Requiring Medical Intervention in a Large Cohort of Adults With Diabetes Receiving Care in U.S. Integrated Health Care Delivery Systems: 2005-2011. Diabetes Care (2015) 1.01
Evaluation of Finnish Diabetes Risk Score in screening undiagnosed diabetes and prediabetes among U.S. adults by gender and race: NHANES 1999-2010. PLoS One (2014) 1.01
Hypoglycemia: The neglected complication. Indian J Endocrinol Metab (2013) 1.01
Smoking cessation in adults with diabetes: a systematic review and meta-analysis of data from randomised controlled trials. BMJ Open (2014) 1.01
Importance of family/social support and impact on adherence to diabetic therapy. Diabetes Metab Syndr Obes (2013) 1.00
Diagnosis and management of non-alcoholic fatty liver disease and related metabolic disorders: consensus statement from the Study Group of Liver and Metabolism, Chinese Society of Endocrinology. J Diabetes (2013) 1.00
Ambient Air Pollution and Type 2 Diabetes: A Systematic Review of Epidemiologic Research. Curr Environ Health Rep (2014) 1.00
Efficacy and safety of canagliflozin in subjects with type 2 diabetes: systematic review and meta-analysis. Eur J Clin Pharmacol (2014) 0.99
Magnitude of cognitive dysfunction in adults with type 2 diabetes: a meta-analysis of six cognitive domains and the most frequently reported neuropsychological tests within domains. J Int Neuropsychol Soc (2014) 0.99
Time-updated systolic blood pressure and the progression of chronic kidney disease: a cohort study. Ann Intern Med (2015) 0.99
Renaming gestational diabetes mellitus: A psychosocial argument. Indian J Endocrinol Metab (2013) 0.99
Prevalence of vascular complications and factors predictive of their development in young adults with type 1 diabetes: systematic literature review. BMC Res Notes (2014) 0.99
Identifying and meeting the challenges of insulin therapy in type 2 diabetes. J Multidiscip Healthc (2014) 0.98
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med (1993) 102.56
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 101.79
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med (1999) 82.86
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med (2001) 56.11
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care (1997) 49.11
Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med (2008) 47.90
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet (2002) 40.37
Intensive insulin therapy in critically ill patients. N Engl J Med (2001) 40.00
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med (2008) 38.76
10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med (2008) 35.49
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ (2000) 35.06
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (1998) 34.34
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ (1998) 32.73
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet (2005) 32.41
Emerging adulthood. A theory of development from the late teens through the twenties. Am Psychol (2000) 29.80
Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care (2003) 29.49
Diagnosis and classification of diabetes mellitus. Diabetes Care (2010) 28.34
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med (2005) 27.77
International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care (2009) 26.77
Intensive versus conventional glucose control in critically ill patients. N Engl J Med (2009) 26.30
Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med (2008) 25.70
Hyperglycemia and adverse pregnancy outcomes. N Engl J Med (2008) 25.36
Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med (2007) 25.17
Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care (1997) 23.95
Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. JAMA (2005) 23.44
National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med (2003) 23.33
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation (2004) 23.07
Intensive insulin therapy in the medical ICU. N Engl J Med (2006) 22.37
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med (2001) 22.32
Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. J Am Diet Assoc (2002) 22.00
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care (2012) 21.62
Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med (2010) 21.49
Treatment of hypertension in patients 80 years of age or older. N Engl J Med (2008) 21.04
Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med (2001) 20.18
Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med (2008) 19.93
A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med (1997) 19.93
Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med (2008) 19.76
Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med (2004) 19.42
Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med (2007) 18.45
Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med (2008) 18.27
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med (1993) 18.15
International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care (2010) 18.00
Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care (1993) 17.66
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet (2012) 17.29
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med (2001) 17.24
Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol (1985) 17.20
Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med (2008) 17.19
Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med (2005) 16.55
Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med (2010) 16.40
The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care (2001) 15.36
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet (2006) 15.32
Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med (2011) 15.30
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet (2009) 15.00
A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med (2009) 14.40
Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care (2007) 14.35
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet (2010) 14.24
Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med (2009) 13.91
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet (2003) 13.69
Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA (2008) 13.69
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet (2009) 13.64
Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med (2012) 13.59
Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med (1987) 13.50
Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med (2010) 13.25
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet (2005) 13.18
Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract (1995) 12.51
Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med (2008) 12.41
A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med (2009) 12.15
Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet (2006) 11.64
Aliskiren combined with losartan in type 2 diabetes and nephropathy. N Engl J Med (2008) 11.61
Translating the A1C assay into estimated average glucose values. Diabetes Care (2008) 11.55
Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med (2012) 11.25
Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med (2011) 11.11
Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ (2007) 11.09
Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diabetes Care (2001) 10.79
Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med (2010) 10.75
Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ (2000) 10.66
European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr (2012) 10.61
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med (2001) 10.36
Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA (2008) 10.15
Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med (2000) 10.05
Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care (2002) 10.00
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet (2003) 9.98
Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care (2005) 9.97
Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA (2004) 9.91
Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med (1999) 9.83
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. JAMA (2004) 9.74
Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med (2004) 9.67
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet (2002) 9.48
Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care (2008) 9.34
A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med (2003) 9.23
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet (2010) 9.20
Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care (2002) 9.08
Diagnosis and classification of diabetes mellitus. Diabetes Care (2010) 28.34
Standards of medical care in diabetes--2010. Diabetes Care (2010) 24.28
Standards of medical care in diabetes--2011. Diabetes Care (2011) 21.94
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care (2008) 21.05
Standards of medical care in diabetes--2014. Diabetes Care (2014) 20.97
Standards of medical care in diabetes--2012. Diabetes Care (2012) 20.66
Standards of medical care in diabetes--2008. Diabetes Care (2008) 17.23
Standards of medical care in diabetes--2009. Diabetes Care (2009) 15.78
Economic costs of diabetes in the U.S. In 2007. Diabetes Care (2008) 15.73
Standards of medical care in diabetes--2007. Diabetes Care (2007) 12.35
The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care (2005) 11.91
Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care (2005) 9.97
Standards of medical care in diabetes--2006. Diabetes Care (2006) 9.56
Diagnosis and classification of diabetes mellitus. Diabetes Care (2011) 9.37
Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care (2008) 9.34
Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care (2004) 9.16
Diagnosis and classification of diabetes mellitus. Diabetes Care (2012) 9.03
Economic costs of diabetes in the US in 2002. Diabetes Care (2003) 8.92
Diagnosis and classification of diabetes mellitus. Diabetes Care (2004) 8.66
Diagnosis and classification of diabetes mellitus. Diabetes Care (2014) 8.37
Diagnosis and classification of diabetes mellitus. Diabetes Care (2008) 8.16
Diagnosis and classification of diabetes mellitus. Diabetes Care (2006) 7.91
Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care (2005) 7.81
Diagnosis and classification of diabetes mellitus. Diabetes Care (2009) 7.66
Diagnosis and classification of diabetes mellitus. Diabetes Care (2013) 6.83
Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care (2007) 6.24
Standards of medical care in diabetes. Diabetes Care (2005) 5.98
Gestational diabetes mellitus. Diabetes Care (2004) 5.77
American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care (2009) 5.41
Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care (2013) 4.85
Diagnosis and classification of diabetes mellitus. Diabetes Care (2007) 4.78
Standards of medical care for patients with diabetes mellitus. Diabetes Care (2003) 4.64
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation (2006) 4.61
Diagnosis and classification of diabetes mellitus. Diabetes Care (2005) 4.47
Peripheral arterial disease in people with diabetes. Diabetes Care (2003) 4.36
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care (2007) 4.30
(2) Classification and diagnosis of diabetes. Diabetes Care (2015) 4.29
Screening for type 2 diabetes. Diabetes Care (2004) 4.27
Retinopathy in diabetes. Diabetes Care (2004) 4.25
Nephropathy in diabetes. Diabetes Care (2004) 4.08
Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes Care (2010) 3.98
American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract (2009) 3.96
Standards of medical care in diabetes. Diabetes Care (2004) 3.95
Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care (2008) 3.72
Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care (2008) 3.65
Executive summary: Standards of medical care in diabetes--2012. Diabetes Care (2012) 3.47
Postprandial blood glucose. American Diabetes Association. Diabetes Care (2001) 3.38
Consensus development conference on antipsychotic drugs and obesity and diabetes. J Clin Psychiatry (2004) 3.36
Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation (2004) 3.35
Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003. Circulation (2003) 3.22
Tests of glycemia in diabetes. Diabetes Care (2004) 3.03
Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. Circulation (2004) 2.91
Diabetic ketoacidosis in infants, children, and adolescents: A consensus statement from the American Diabetes Association. Diabetes Care (2006) 2.86
Diabetes care at diabetes camps. Diabetes Care (2006) 2.75
Executive summary: Standards of medical care in diabetes--2014. Diabetes Care (2014) 2.59
Nutrition Recommendations and Interventions for Diabetes: a position statement of the American Diabetes Association. Diabetes Care (2007) 2.56
Standards of medical care for patients with diabetes mellitus. Diabetes Care (2002) 2.44
Exercise and type 2 diabetes: American College of Sports Medicine and the American Diabetes Association: joint position statement. Exercise and type 2 diabetes. Med Sci Sports Exerc (2010) 2.44
Diabetes care in the school and day care setting. Diabetes Care (2012) 2.41
Hyperglycemic crises in diabetes. Diabetes Care (2004) 2.38
Executive summary: standards of medical care in diabetes--2011. Diabetes Care (2011) 2.33
(8) Cardiovascular disease and risk management. Diabetes Care (2015) 2.31
2. Classification and Diagnosis of Diabetes. Diabetes Care (2016) 2.26
Gestational diabetes mellitus. Diabetes Care (2003) 2.22
Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary. Diabetes Care (2010) 2.17
Gestational diabetes mellitus. Diabetes Care (2000) 1.97
Standards of medical care for patients with diabetes mellitus. Diabetes Care (2000) 1.93
Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care (2003) 1.91
Screening for type 2 diabetes. Diabetes Care (2003) 1.89
Dyslipidemia management in adults with diabetes. Diabetes Care (2004) 1.89
Hyperglycemic crises in patients with diabetes mellitus. Diabetes Care (2001) 1.89
Diabetic nephropathy. Diabetes Care (2003) 1.87
Physical activity/exercise and diabetes. Diabetes Care (2004) 1.84
Hypertension management in adults with diabetes. Diabetes Care (2004) 1.79
Tests of glycemia in diabetes. Diabetes Care (2003) 1.79
Nutrition principles and recommendations in diabetes. Diabetes Care (2004) 1.78
(4) Foundations of care: education, nutrition, physical activity, smoking cessation, psychosocial care, and immunization. Diabetes Care (2015) 1.75
Prevention or delay of type 2 diabetes. Diabetes Care (2004) 1.73
Insulin administration. Diabetes Care (2004) 1.70
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. J Am Coll Cardiol (2007) 1.69
Diabetes and driving. Diabetes Care (2012) 1.66
Clinical Practice Recommendations 2005. Diabetes Care (2005) 1.62
7. Approaches to Glycemic Treatment. Diabetes Care (2016) 1.62
Hyperglycemic crises in patients with diabetes mellitus. Diabetes Care (2003) 1.61
Diabetic retinopathy. Diabetes Care (2003) 1.61
Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care (2002) 1.56
Preconception care of women with diabetes. Diabetes Care (2004) 1.56
Standards of medical care in diabetes-2015 abridged for primary care providers. Clin Diabetes (2015) 1.56
Aspirin therapy in diabetes. Diabetes Care (2004) 1.55
Diabetic retinopathy. Diabetes Care (2003) 1.52